| Literature DB >> 36190649 |
Shuxin Wang1, Zhengyang Luo1, Ludong Yuan1, Xiaofang Lin1, Yuting Tang1, Leijing Yin1, Pengfei Liang2, Bimei Jiang3.
Abstract
tRNA-derived small RNAs (tsRNAs) are non-coding RNAs with diverse functions in various diseases. Although research on tsRNAs has focused on their roles in cancer, such as gene expression regulation to influence cancer progression and realize clinical effects, a growing number of studies are investigating the association of tsRNAs with cardiovascular diseases (CVDs), including atherosclerosis, myocardial infarction, and pulmonary hypertension. tsRNA expression varies across these diseases and could be regulated by epigenetics, tsRNA structure, and tRNA-binding proteins. tsRNAs play key roles in CVD progression, including the regulation of protein synthesis, and the different mechanisms underlying these functional roles of tsRNAs have been elucidated. Furthermore, tsRNAs are potential diagnostic biomarkers and therapeutic targets in CVDs. In this review, we summarize the biogenesis, classification, and regulation of tsRNAs and their potential application for CVD diagnosis and therapy. We also highlight the current challenges and provide perspectives for further investigation.Entities:
Keywords: Atherosclerosis; Cardiac hypertrophy; Myocardial ischemia; Pulmonary hypertension; tRNA-derived small RNAs
Year: 2022 PMID: 36190649 DOI: 10.1007/s12265-022-10322-0
Source DB: PubMed Journal: J Cardiovasc Transl Res ISSN: 1937-5387 Impact factor: 3.216